trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] Incorporated in PLGA Nanoparticles for the Delivery of Nitric Oxide to B16-F10 Cells: Cytotoxicity and Phototoxicity

被引:33
作者
Gomes, Anderson J. [1 ]
Espreafico, Enilza M. [2 ]
Tfouni, Elia [3 ]
机构
[1] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, Sao Paulo, Brazil
[3] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
ruthenium nitrosyl; nitric oxide; nanoparticles; PLGA; cytotoxicity; phototoxicity; B16-F10; cyclam; Hedta; nitric oxide donors; RUTHENIUM COMPLEXES; PHOTOCHEMICAL-REACTIONS; BACTERIOCHLOROPHYLL-A; BIOLOGICAL-ACTIVITY; ANTICANCER DRUGS; CELLULAR UPTAKE; IN-VITRO; NO; RELEASE; MICROPARTICLES;
D O I
10.1021/mp3005534
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The immobilization and characterization of trans-[Ru(NO)Cl(cyclam)](PF6)(2) (cyclam = 1,4,8,11-tetraazacyclotetradecane), and [Ru(NO)(Hedta)] (Hedta = ethylenediaminetetraacetic acid) entrapped in poly(D,L-lactic-co-glycolic) acid (PLGA) nanoparticles (NP) using the double emulsification process is described. Scanning electron microscopy and dynamic light scattering revealed that the particles are spherical in shape, have a size distribution between 220 and 840 nm of diameter, and have a tendency to aggregate confirmed by a zeta potential between -3.2 and +3.5 mV. Using this method the loading efficiency was 26% for trans-[Ru(NO)Cl(cyclam)](PF6)(2) and 32% for [Ru(NO)(Hedta)]. The release of the complexes from the NPs shows that cyclam-NP and Hedta-NP exhibited a two-phase exponential association release pattern, which was characterized by an initial complex burst during the first 24 h, followed by a slower release phase complex profile, due to a few pores observed in surface of nanoparticles using atomic force microscopy. The in vitro cytotoxic activity of the nitrosyl complexes in solution and incorporated in PLGA nanoparticles on melanoma cancer cells (cell line B16-F10) was investigated. The lower cytotoxicity of trans-[RuCl(cyclam)(NO)](2+) (12.4 +/- 2.6%) and [Ru(NO)(Hedta)] (4.0 +/- 2.7%) in solution compared to that of trans-[Ru(NO)(NH3)(4)py](3+) (46.1 +/- 6.4%) is consistent with the rate constant release of NO of these complexes (k(-NO) = 6.2 x 10(-4) s(-1), 2.0 x 10(-3) s(-1), and 6.0 x 10(-2) s(-1), respectively); the cytotoxicities are also inhibited in the presence of the NO scavenger carboxy-PTIO. The phototoxicity of these complexes is due to NO release, which lead to 53.8 +/- 6.2% of cell death in the. presence of trans-[Ru(NO)Cl(cyclam)](PF6)(2) and 22.3 +/- 5.1% in the presence of [Ru(NO)(Hedta)]. The PLGA nanoparticles loaded with trans-[Ru(NO)Cl(cyclam)](PF6)(2) and [Ru(NO)(Hedta)] exerted in vitro a reduced activity against melanoma cells when compared to the activity of complex in solution (nonentrapped in nanoparticles). Blank PLGA nanoparticles did not exhibit cytotoxicity. In the presence of light and of ruthenium nitrosyl complexes or cyclam-NP and Hedta-NP, B16-F10 cells displayed a considerable damage of the surface with rupture of the plasma membrane. This behavior is an indicative of the efficiency of the DDS to deliver the NO from the entrapped complex when photoinduced.
引用
收藏
页码:3544 / 3554
页数:11
相关论文
共 89 条
  • [11] [Ru-2(II)(ttha)(H2O)(2)](2-) is a rapid NO scavenger (ttha(6-) = triethylenetetraminehexaacetate)
    Chen, Y
    Shepherd, RE
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 1997, 68 (03) : 183 - 193
  • [12] Ruthenium metallopharmaceuticals
    Clarke, MJ
    [J]. COORDINATION CHEMISTRY REVIEWS, 2002, 232 (1-2) : 69 - 93
  • [13] A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles
    Cohen-Sela, Einat
    Chorny, Michael
    Koroukhov, Nickolay
    Danenberg, Haim D.
    Golomb, Gershon
    [J]. JOURNAL OF CONTROLLED RELEASE, 2009, 133 (02) : 90 - 95
  • [14] Nitric oxide release: Part III. Measurement and reporting
    Coneski, Peter N.
    Schoenfisch, Mark H.
    [J]. CHEMICAL SOCIETY REVIEWS, 2012, 41 (10) : 3753 - 3758
  • [15] Controlling drug nanoparticle formation by rapid precipitation
    D'Addio, Suzanne M.
    Prud'homme, Robert K.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (06) : 417 - 426
  • [16] Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution
    Davies, KM
    Wink, DA
    Saavedra, JE
    Keefer, LK
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (23) : 5473 - 5481
  • [17] Kinetics of nitric oxide scavenging by ruthenium(III) polyaminocarboxylates: Novel therapeutic agents for septic shock
    Davies, NA
    Wilson, MT
    Slade, E
    Fricker, SP
    Murrer, BA
    Powell, NA
    Henderson, GR
    [J]. CHEMICAL COMMUNICATIONS, 1997, (01) : 47 - 48
  • [18] DEGOMES A, 2006, FASEB J 1, V20, pA101
  • [19] In silico evolution of substrate selectivity:: comparison of organometallic ruthenium complexes with the anticancer drug cisplatin
    Deubel, Dirk V.
    Lau, Justin Kai-Chi
    [J]. CHEMICAL COMMUNICATIONS, 2006, (23) : 2451 - 2453
  • [20] Nanoparticles containing ketoprofen and acrylic polymers prepared by an aerosol flow reactor method -: art. no. 68
    Eerikäinen, H
    Peltonen, L
    Raula, J
    Hirvonen, J
    Kauppinen, EI
    [J]. AAPS PHARMSCITECH, 2004, 5 (04)